Pfizer Launch Plans For Lyrica Fibromyalgia Approval Include Patient Groups
Executive Summary
Pfizer's first steps in marketing Lyrica's new indication for fibromyalgia - the first FDA approval for the condition - will be partnering with patient advocacy groups to raise awareness and conduct educational programs
You may also be interested in...
Cymbalta Fibromyalgia Approval Sets Another REMS Precedent
FDA's approval of Lilly's Cymbalta (duloxetine) for treatment of fibromyalgia sets another precedent in the new era of Risk Evaluation and Mitigation Strategies: the agency will not necessarily seek a formal REMS for products already accompanied by mandatory medication guides
Cymbalta Fibromyalgia Approval Sets Another REMS Precedent
FDA's approval of Lilly's Cymbalta (duloxetine) for treatment of fibromyalgia sets another precedent in the new era of Risk Evaluation and Mitigation Strategies: the agency will not necessarily seek a formal REMS for products already accompanied by mandatory medication guides
Pfizer Matches Lilly In Grant Spending For 1st Quarter; Fibromyalgia Is Focus
Pfizer and Lilly dispensed comparable amounts in grants during the first quarter of 2008, as revealed by Pfizer's inaugural online posting of gifts and charitable donations, unveiled May 15